Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China flag China · Delayed Price · Currency is CNY
36.85
+0.25 (0.68%)
Mar 10, 2026, 3:00 PM CST

Hangzhou Biotest Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Cash & Equivalents
-1,5911,9071,9401,368
Upgrade
Short-Term Investments
--10--
Upgrade
Trading Asset Securities
-60.26-100.06360.84
Upgrade
Cash & Short-Term Investments
1,5241,6511,9172,0401,729
Upgrade
Cash Growth
-7.72%-13.88%-6.01%18.02%561.86%
Upgrade
Accounts Receivable
-97.4661.8938.82146.91
Upgrade
Other Receivables
-4.272.81.68.32
Upgrade
Receivables
-101.7364.6840.42155.23
Upgrade
Inventory
-73.499.32135.2141.7
Upgrade
Other Current Assets
-51.575.3719.67.2
Upgrade
Total Current Assets
-1,8782,0872,2352,033
Upgrade
Property, Plant & Equipment
-408.81261.58244.68231.02
Upgrade
Long-Term Investments
-19.32.844040
Upgrade
Other Intangible Assets
-275.16208.71213.7120.35
Upgrade
Long-Term Deferred Tax Assets
-11.814.4413.163.01
Upgrade
Long-Term Deferred Charges
--0.110.210.29
Upgrade
Other Long-Term Assets
-9.155.084.54104.13
Upgrade
Total Assets
-2,6022,5802,7522,432
Upgrade
Accounts Payable
-56.4558.3588.72224.32
Upgrade
Accrued Expenses
-19.0820.0225.9426.32
Upgrade
Short-Term Debt
-0.440.590.355.64
Upgrade
Current Portion of Leases
--2.455.12.28
Upgrade
Current Income Taxes Payable
-0.02--39
Upgrade
Current Unearned Revenue
-7.3947.1644.6818.56
Upgrade
Other Current Liabilities
-95.2320.856.281.44
Upgrade
Total Current Liabilities
-178.62149.43171.08317.56
Upgrade
Long-Term Leases
---2.194.55
Upgrade
Long-Term Unearned Revenue
-11.178.696.431.25
Upgrade
Long-Term Deferred Tax Liabilities
--0.711.16-
Upgrade
Other Long-Term Liabilities
---8.43-
Upgrade
Total Liabilities
-189.79158.82189.29323.36
Upgrade
Common Stock
-106.67106.67106.67106.67
Upgrade
Additional Paid-In Capital
-790.45813.33814.94814.94
Upgrade
Retained Earnings
-1,5431,5101,6381,185
Upgrade
Treasury Stock
--31.61-14.76--
Upgrade
Comprehensive Income & Other
-0.94-0.361.210.7
Upgrade
Total Common Equity
2,3392,4092,4152,5612,107
Upgrade
Minority Interest
-2.875.511.041.05
Upgrade
Shareholders' Equity
2,3402,4122,4212,5622,108
Upgrade
Total Liabilities & Equity
-2,6022,5802,7522,432
Upgrade
Total Debt
0.190.443.047.6412.47
Upgrade
Net Cash (Debt)
1,5231,6511,9142,0321,716
Upgrade
Net Cash Growth
-7.71%-13.77%-5.81%18.43%586.22%
Upgrade
Net Cash Per Share
10.4211.2012.8313.6014.15
Upgrade
Filing Date Shares Outstanding
107.88148.78146.38149.33149.33
Upgrade
Total Common Shares Outstanding
107.88148.78148.7149.33149.33
Upgrade
Working Capital
-1,6991,9372,0641,715
Upgrade
Book Value Per Share
19.0616.2016.2417.1514.11
Upgrade
Tangible Book Value
2,0682,1342,2072,3482,087
Upgrade
Tangible Book Value Per Share
16.8514.3514.8415.7213.97
Upgrade
Buildings
-306.67193.65194.71189.13
Upgrade
Machinery
-96.1790.9281.6166.19
Upgrade
Construction In Progress
-87.2339.659.85-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.